arrow
M

Matthias Simon

Bielefeld University
H指数:68
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems

脑膜瘤复发风险估计值在不同观察队列中的差异:日历时间、WHO分类、地理环境和医疗系统的影响

2026-08-280
OAAI
Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients

WHO-2型脑膜瘤手术辅助分次放射治疗的疗效比较:一项包含1,452例患者的多中心回顾性队列研究(分为全切除与非全切除两组)

2026-02-090
OAAI
Enhancing decision-making in glioblastoma surgery through an explainable human-AI collaboration: an international multicenter model development and external validation study

通过可解释的人机协作提升胶质母细胞瘤手术的决策制定:一项国际多中心模型开发与外部验证研究

2025-11-270
OAAI
EANS-EANO guidelines on the extent of resection in gliomas

EANS-EANO关于胶质瘤切除范围的指南

2025-11-010
PRE
NEUROSURGEONS' PERSPECTIVE ON SURGICAL TREATMENT OF GLIOBLASTOMA: PRACTICES, BELIEFS AND WILLINGNESS TO RANDOMIZE IN SURGICAL TRIALS

神经外科医生对胶质母细胞瘤手术治疗的看法:实践、信念以及参与手术试验随机化的意愿

2025-11-010
OAAI
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells

脑膜瘤中的肿瘤相关巨噬细胞:一种优于T细胞获益的新型不良生存预后生物标志物

2025-10-090
OA
A INTEGRATIVE MULTIOMICS ANALYSIS IDENTIFIES TUMOR-ASSOCIATED MACROPHAGES AS NOVEL INDEPENDENT BIOMARKER FOR POOR SURVIVAL IN MENINGIOMAS

整合多组学分析确定了肿瘤相关巨噬细胞作为脑膜瘤不良预后的新型独立生物标志物

2025-10-010
OAAI
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases

确定内侧颞叶癫痫手术的基准结果: 1119例全球多中心分析

2024-02-244
OAAI
The importance of considering competing risks in recurrence analysis of intracranial meningioma
2024-02-100
OAAI
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas
2023-10-076
OAAI